Irisz Lippai-Nagy – CEO, AmCham Hungary
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
AmCham provides members with an opportunity to actively and directly participate in defining, developing, discussing and resolving issues of common interest impacting the operations of their respective businesses and organizations. Through active member participation and cooperation with Policy Task Forces and Committees, AmCham strives to create a space for a thriving and dynamic business scene in Hungary.
ADVOCACY
AmCham Hungary represents the interest of the entire membership to make ‘doing-business’ in Hungary easier, more efficient and reliable. According to its new strategy AmCham will use a Policy Agenda as a guideline for its Advocacy efforts each year.
Our way of working:
Collective interest – on behalf of a given sector or the entire membership
Issues verified by expert members (AmCham Committees)
Regulations serving the interest of all actors of the Hungarian economy
We continuously talk to the decision makers about issues effecting business conduct in Hungary. To make these efforts as efficient as possible we have entered a number of cooperation agreements with the government since 2011.
NETWORK
AmCham is a network. The power of networks was one of our Visionary event topics in 2014 and the words of Professor Barabási reinforced us incorporating the idea of network in our new strategy: „if networks are expanding, links will want to join the most popular hubs. […] It is hubs that make the difference.”
AmCham Hungary provides Exclusive Networking Possibilities to its members in order to have various opportunities to interact on a formal business level as well as a social level exist through various types of events:
Regular monthly events (Business Forums, Seminar & Cocktails)
Conferences (regular conferences on taxation, diversity, labor and education issues)
Ad hoc business events (Global Leaders on the AmCham Podium, Career School)
Networking events (Business After Hours, Insight dinners)
Special events (Independence Day Family Party, Thanksgiving Dinner, Annual Sports Day, U.S. Election Night Party)
Contact
H-1051 Budapest, Szent István tér 11.
Phone: +36 1 266 9880 | Fax: +36 1 266 9888
E-mail: info@amcham.hu
Web: www.amcham.hu
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
AmCham Hungary, one of the largest American Chambers of Commerce in Central and Eastern Europe, discusses their advocacy efforts, particularly highlighting the chamber’s recently established Healthy Nation Policy Task Force…
The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of Prime Minister…
Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application…
Dr Beata Sperlagh, Deputy Director of the Institute of Experimental Medicine (IEM), shares her insights on the institute’s involvement in research and with the private sector, the key strengths of…
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
Oliver Strommer, newly appointed executive director of the British Chamber of Commerce in Hungary (BCCH), introduces the Chamber and its refocused aim of becoming a more dynamic player in business…
Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort between the public and private sectors…
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European market with more affordable biologic medicines and bolstering Hungary’s footprint in…
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most affected areas and oncology patients are now also…
Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria and Slovakia.leading some organisations to urge the government to increase…
Hungary’s Minister of Finance Mihály Varga has repeatedly underlined the importance of the pharmaceutical industry to the country’s economy in recent weeks. With this strong governmental backing, pharma stands to…
Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in…
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country’s innovative pharma association has taken the initiative to suggest measures that…
See our Cookie Privacy Policy Here
